| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -153.00K | 16.47M | 3.83M | 14.02M | 16.33M | 2.72M |
| Gross Profit | -1.74M | 16.47M | 3.83M | 13.28M | 12.96M | -409.00K |
| EBITDA | 12.67M | 0.00 | 0.00 | 470.00K | 0.00 | 0.00 |
| Net Income | 11.06M | 13.62M | 2.90M | 8.43M | 13.84M | 16.61M |
Balance Sheet | ||||||
| Total Assets | 136.01M | 98.31M | 65.36M | 50.96M | 43.13M | 55.59M |
| Cash, Cash Equivalents and Short-Term Investments | 10.73M | 2.56M | 4.76M | 11.63M | 10.51M | 1.60M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.20M | 1.73M | 1.10M | 1.17M | 2.13M | 2.94M |
| Stockholders Equity | 134.81M | 96.58M | 64.26M | 49.79M | 41.01M | 52.66M |
Cash Flow | ||||||
| Free Cash Flow | -1.90M | -434.00K | -524.00K | -1.39M | -7.21M | -783.00K |
| Operating Cash Flow | -1.90M | -434.00K | -524.00K | -1.39M | -7.21M | -783.00K |
| Investing Cash Flow | -28.48M | -20.61M | -17.76M | 2.51M | 41.66M | -3.61M |
| Financing Cash Flow | 36.78M | 18.85M | 11.42M | 0.00 | -25.56M | -867.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £57.38M | 7.35 | 10.95% | ― | 9.90% | 37.20% | |
72 Outperform | £94.83M | 7.57 | 30.24% | 8.61% | -11.43% | -17.65% | |
69 Neutral | ― | 2.42 | 9.98% | ― | -2.90% | -61.88% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
48 Neutral | £6.30M | -7.39 | -140.34% | ― | ― | ― | |
48 Neutral | £4.61M | -1.85 | -12.33% | ― | ― | ― | |
40 Underperform | $1.81M | -0.04 | ― | ― | -96.59% | 93.69% |